|
|
|
|
|
Issuer Free Writing |
|
|
Prospectus |
|
|
Filed Pursuant to Rule 433 |
|
|
Registration Statement No. |
|
|
333-137376 |
|
|
January 10, 2007 |
BIOMED REALTY TRUST, INC.
7.375% SERIES A CUMULATIVE REDEEMABLE PREFERRED STOCK
(LIQUIDATION PREFERENCE $25.00 PER SHARE)
Final Term Sheet
Issuer: BioMed Realty Trust, Inc.
Security: 7.375% Series A Cumulative Redeemable Preferred Stock
CUSIP: 09063H206
Size: 8,000,000 shares Over-allotment option: 1,200,000 shares
Type of security: SEC RegisteredRegistration Statement No. 333-137376; preliminary prospectus
supplement dated January 9, 2007
Public offering price: $25.00 per share, plus accrued dividends, if any, from the date of original
issuance; $200,000,000 total
Maturity: Perpetual
Underwriting discounts and commissions: $0.7875 per share; $6,300,000 total ($7,245,000 if
over-allotment option is exercised in full)
Proceeds to the Company, before expenses: $24.2125 per share; $193,700,000 total ($222,755,000
if over-allotment option is exercised in full)
Expected net proceeds after deducting underwriting discounts and commissions and estimated
transaction expenses payable by the Company: $193,200,000 ($222,255,000 if over-allotment option is
exercised in full).
Dividend rate: 7.375% per annum of the liquidation preference per share; $1.84375 per annum per
share, cumulative from and including the date of original issue (subject to the dividend rate
step-up to 8.375% per annum of the liquidation preference per share described in the prospectus
supplement)
Optional redemption: On or after January 18, 2012 (subject to the special optional redemption
right described in the prospectus supplement)
Settlement and delivery date: January 18, 2007
Selling concession: Not to exceed $0.50 per share
Reallowance to other dealers: Not to exceed $0.45 per share
|
|
|
|
|
Joint Bookrunners:
|
|
Wachovia Capital Markets, LLC
|
|
1,734,400 shares |
|
|
Morgan Stanley & Co. Incorporated
|
|
1,732,800 shares |
|
|
Raymond James & Associates, Inc.
|
|
1,732,800 shares |